Contributions of vitamin D in the management of depressive symptoms and cardiovascular risk factors: study protocol for a randomized, double-blind, placebo-controlled clinical trial
Abstract Background Depression is a major cause of chronic disability throughout the world and an important cardiovascular risk factor, increasing the relative risk of coronary artery disease as well as rates of cardiovascular morbidity and mortality. Concomitant to the high prevalence of depression...
Main Authors: | Catarina Magalhães Porto, Tatiana de Paula Santana da Silva, Everton Botelho Sougey |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3699-3 |
Similar Items
-
Effect of Vitamin D Supplementation on Depression in Adults: A Systematic Review of Randomized Controlled Trials (RCTs)
by: Dominika Guzek, et al.
Published: (2023-02-01) -
Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
by: Atefeh Zandifar, et al.
Published: (2021-01-01) -
Vitamin D3 as adjunctive therapy in the treatment of depression in tuberculosis patients: a short-term pilot randomized double-blind controlled study
by: Zhang L, et al.
Published: (2018-11-01) -
Effect of vitamin D supplementation on depressive symptoms and psychological wellbeing in healthy adult women: a double-blind randomised controlled clinical trial
by: Maria A. Choukri, et al.
Published: (2018-01-01) -
The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis
by: Fereshteh Ashtari, et al.
Published: (2013-01-01)